The Investing Club holds its 'Morning Meeting' every weekday at 10:20 a.m. ET.
Every weekday the CNBC Investing Club with Jim Cramer holds a "Morning Meeting" livestream at 10:20 a.m. ET. Here's a recap of Friday's key moments. 1. Wall Street was bouncing higher Friday after, as Jim Cramer put it, a "really bad day" in the prior session. Thursday's late-day decline happened as bond yields rose on "good economic data being viewed as bad news." The market also sold off despite a 9% post-earnings increase in shares of Nvidia .
Four Club names report earnings next week: Salesforce, Best Buy, Foot Locker and Costco. Salesforce is on Wednesday after the closing bell. The stock was down in sympathy with HR software company Workday . Cramer said he was "almost tempted to buy some" Salesforce on the dip. Best Buy is on Thursday before the opening bell. Cramer said he was early in buying the electronic retailer in case artificial intelligence PCs came to market quickly. That didn't happen. But it will.
Health Care Industry Pharmaceuticals Retail Industry Breaking News: Business Technology Breaking News: Technology Costco Wholesale Corp Foot Locker Inc Best Buy Co Inc Salesforce Inc Breaking News: Markets Markets Investment Strategy Jim Cramer Morning Meeting Recaps NVIDIA Corp Novo Nordisk A/S Workday Inc Nike Inc Business News
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Why Lilly And Novo Nordisk Will Keep Dominating The Market For Blockbuster GLP-1 DrugsAlex Knapp is a senior editor at Forbes covering healthcare, science, and cutting edge technology who joined Forbes in 2011. He's written dozens of profiles of entrepreneurs across a variety of fields and done deep dives into technological trends from superconductors to space travel to pharmaceuticals.
Read more »
Eli Lilly stock climbs on gross margin beat, raised 2024 revenue outlookEli Lilly stock climbs on gross margin beat, raised 2024 revenue outlook
Read more »
Amgen stock soars on weight loss injection progress as Novo Nordisk, Eli Lilly shares slideAmgen's update fueled concerns about potential new competition in the weight loss drug market, sending shares of Novo Nordisk and Eli Lilly lower.
Read more »
Here's what's driving Friday's stock action in Apple, Coterra and Eli LillyThe Investing Club holds its 'Morning Meeting' every weekday at 10:20 a.m. ET.
Read more »
Novo Nordisk, Eli Lilly drop on Amgen competition concernsNovo Nordisk, Eli Lilly drop on Amgen competition concerns
Read more »
Amgen, newer rivals could threaten Novo Nordisk and Eli Lilly's weight loss drug dominance Amgen, Viking Therapeutics, Altimmune, AstraZeneca, Boehringer Ingelheim and Zealand Pharma are making encouraging progress on their own treatments.
Read more »